Log In
BCIQ
Print this Print this
 

oral Debio 1450 (formerly oral AFN-1720)

  Manage Alerts
Collapse Summary General Information
Company Debiopharm Group
DescriptionOral formulation of a small molecule prodrug inhibitor of the bacterial fabI enoyl-(acyl carrier protein) reductase
Molecular Target fabI enoyl-(acyl carrier protein) reductase
Mechanism of ActionfabI enoyl-(acyl carrier protein) reductase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/17/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today